» Articles » PMID: 37747763

HPV Persistence After Cervical Surgical Excision of High-grade Cervical Lesions

Overview
Specialty Oncology
Date 2023 Sep 25
PMID 37747763
Authors
Affiliations
Soon will be listed here.
Citing Articles

Coping strategies utilized by patients with cervical cancer: an explorative qualitative study at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania.

Ambikile J, Msengi E, Chona E, Gosse R BMC Womens Health. 2025; 25(1):59.

PMID: 39934726 PMC: 11816738. DOI: 10.1186/s12905-024-03536-8.


Editorial: Tailoring treatment in invasive and non-invasive cervical pathology volume II.

Di Donato V, Golia DAuge T, Soderini A, Giannini A, Plotti F Front Surg. 2025; 11():1540134.

PMID: 39840259 PMC: 11747380. DOI: 10.3389/fsurg.2024.1540134.


GX-188E DNA vaccine plus pembrolizumab in HPV 16- and/or 18-positive recurrent or advance cervical cancer: a phase 2 trial.

Lim M, Choi Y, Hur S, Kim Y, No J, Kim B EClinicalMedicine. 2025; 74():102716.

PMID: 39823099 PMC: 11736335. DOI: 10.1016/j.eclinm.2024.102716.


Value of intraoperative post-conisation human papillomavirus testing in predicting residual or recurrence after treatment with a loop electrosurgical excision procedure in women with HR-HPV positive and cervical high-grade squamous intraepithelial....

Xia W, Dai X, Hu Y, Yang S, Chen C, Li X BMC Cancer. 2024; 24(1):1496.

PMID: 39639227 PMC: 11619614. DOI: 10.1186/s12885-024-13272-9.


Advances in cervical cancer: current insights and future directions.

Xu M, Cao C, Wu P, Huang X, Ma D Cancer Commun (Lond). 2024; 45(2):77-109.

PMID: 39611440 PMC: 11833674. DOI: 10.1002/cac2.12629.